Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Tanuja N Gengiah, Andrew L Gray, Kogieleum Naidoo & Quarraisha Abdool Karim. (2011) Initiating antiretrovirals during tuberculosis treatment: a drug safety review. Expert Opinion on Drug Safety 10:4, pages 559-574.
Read now
Read now
Articles from other publishers (15)
Josiah Tatenda Masuka, Anisa Mosam & Star Khoza. (2020) Exploring the utility of a spontaneous adverse drug reaction reporting system in identifying drug–drug interactions between antiretrovirals, antitubercular drugs, and cotrimoxazole: a case/non-case analysis. Drugs & Therapy Perspectives 36:12, pages 583-589.
Crossref
Crossref
Catherine Riou, Elsa Du Bruyn, Sheena Ruzive, Rene T Goliath, Cecilia S Lindestam Arlehamn, Alessandro Sette, Alan Sher, Daniel L Barber & Robert J Wilkinson. (2020)
Disease extent and anti‐tubercular treatment response correlates with
Mycobacterium tuberculosis
‐specific CD4 T‐cell phenotype regardless of HIV‐1 status
. Clinical & Translational Immunology 9:9.
Crossref
Crossref
Chun-Wei Tung, Chia-Chi Wang, Shan-Shan Wang & Pinpin Lin. (2018) ChemDIS-Mixture: an online tool for analyzing potential interaction effects of chemical mixtures. Scientific Reports 8:1.
Crossref
Crossref
Namrata Anand, K. K. G. Ramakrishna, Munna P. Gupt, Vinita Chaturvedi, Shubhra Singh, Kishore K. Srivastava, Prapunjika Sharma, Niyati Rai, Ravishankar Ramachandran, A. K. Dwivedi, Varsha Gupta, Brijesh Kumar, Smriti Pandey, Praveen K. Shukla, Shailandra K. Pandey, Jawahar Lal & Rama Pati Tripathi. (2013)
Identification of 1-[4-Benzyloxyphenyl)-but-3-enyl]-1
H
-azoles as New Class of Antitubercular and Antimicrobial Agents
. ACS Medicinal Chemistry Letters 4:10, pages 958-963.
Crossref
Crossref
Ivani Pauli, Ricardo N. dos Santos, Diana C. Rostirolla, Leonardo K. Martinelli, Rodrigo G. Ducati, Luís F. S. M. Timmers, Luiz A. Basso, Diógenes S. Santos, Rafael V. C. Guido, Adriano D. Andricopulo & Osmar Norberto de Souza. (2013)
Discovery of New Inhibitors of
Mycobacterium tuberculosis
InhA Enzyme Using Virtual Screening and a 3D-Pharmacophore-Based Approach
. Journal of Chemical Information and Modeling 53:9, pages 2390-2401.
Crossref
Crossref
G.L. BirbeckJ.A. FrenchE. PeruccaD.M. SimpsonH. FraimowJ.M. GeorgeJ.F. OkuliczD.B. CliffordH. HachadR.H. Levy. (2012) Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS. Neurology 78:2, pages 139-145.
Crossref
Crossref
Gretchen L. Birbeck, Jacqueline A. French, Emilio Perucca, David M. Simpson, Henry Fraimow, Jomy M. George, Jason F. Okulicz, David B. Clifford, Houda Hachad & René H. Levy for the Quality Standards subc. (2012) Antiepileptic drug selection for people with HIV/AIDS: Evidence-based guidelines from the ILAE and AAN. Epilepsia 53:1, pages 207-214.
Crossref
Crossref
James A. Seddon, Anneke C. Hesseling, Ben J. Marais, Helen McIlleron, Charles A. Peloquin, Peter R. Donald & H. Simon Schaaf. (2012) Paediatric use of second-line anti-tuberculosis agents: A review. Tuberculosis 92:1, pages 9-17.
Crossref
Crossref
Xiaoping Zhang, Scott Fettner, Elke Zwanziger, Lucy Rowell & Miklos Salgo. (2011) Pharmacokinetic Interaction Study of Ritonavir-Boosted Saquinavir in Combination with Rifabutin in Healthy Subjects. Antimicrobial Agents and Chemotherapy 55:2, pages 680-687.
Crossref
Crossref
S. Bonora, A. Mondo, L. Trentini, A. Calcagno, A. Lucchini & G. Di Perri. (2008) Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins. Journal of Infection 57:1, pages 78-81.
Crossref
Crossref
Stefano Bonora & Giovanni Di Perri. (2008) Interactions between antiretroviral agents and those used to treat tuberculosis. Current Opinion in HIV and AIDS 3:3, pages 306-312.
Crossref
Crossref
Sten H. Vermund & Naoki Yamamoto. (2007) Co-infection with human immunodeficiency virus and tuberculosis in Asia. Tuberculosis 87, pages S18-S25.
Crossref
Crossref
François‐Xavier Blanc, Diane V. Havlir, Philip C. Onyebujoh, Sok Thim, Anne E. Goldfeld & Jean‐François Delfraissy. (2007) Treatment Strategies for HIV‐Infected Patients with Tuberculosis: Ongoing and Planned Clinical Trials. The Journal of Infectious Diseases 196:s1, pages S46-S51.
Crossref
Crossref
Joel Fleury Djoba Siawaya, Morten Ruhwald, Jesper Eugen-Olsen & Gerhard Walzl. (2007) Correlates for disease progression and prognosis during concurrent HIV/TB infection. International Journal of Infectious Diseases 11:4, pages 289-299.
Crossref
Crossref
David Back, Sara Gibbons & Saye Khoo. (2006) An Update on Therapeutic Drug Monitoring for Antiretroviral Drugs. Therapeutic Drug Monitoring 28:3, pages 468-473.
Crossref
Crossref